Regulatory norms, US crisis may hit Indian drug R&D - Business Standard

Regulatory norms, US crisis may hit Indian drug R&DBusiness Standard, India - 3 hours agoThen Ranbaxy Laboratories roped in the Department of Science and Technology (DST) to part-fund the second phase of the clinical trials for its anti-malarial ...